Extracellular and intracellular decoys in the tuning of inflammatory cytokines and Toll-like receptors: the new entry TIR8/SIGIRR. (Q35606790)

9 August 2017

1 reference

title

Extracellular and intracellular decoys in the tuning of inflammatory cytokines and Toll-like receptors: the new entry TIR8/SIGIRR. (English)

1 reference

9 August 2017

0 references

1 reference

9 August 2017

Massimo Locati

0 references

Cecilia Garlanda

1 reference

9 August 2017

Nadia Polentarutti

1 reference

9 August 2017

Annunciata Vecchi

1 reference

9 August 2017

language of work or name

1 reference

12 December 2003

1 reference

Journal of Leukocyte Biology

9 August 2017

published in

1 reference

9 August 2017

1 reference

9 August 2017

1 reference

9 August 2017

page(s)

738-742

1 reference

Interleukin-1 receptor antagonist

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1003473

Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1003473

Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1003473

Identification and characterization of SIGIRR, a molecule representing a novel subtype of the IL-1R superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1003473

The type II 'decoy' receptor: a novel regulatory pathway for interleukin 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1003473

The type II "receptor" as a decoy target for interleukin 1 in polymorphonuclear leukocytes: characterization of induction by dexamethasone and ligand binding properties of the released decoy receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1003473

Inhibition of interleukin-1 responsiveness by type II receptor gene transfer: a surface "receptor" with anti-interleukin-1 function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1003473

Interleukin-1 receptor accessory protein interacts with the type II interleukin-1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1003473

The soluble form of IL-1 receptor accessory protein enhances the ability of soluble type II IL-1 receptor to inhibit IL-1 action

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1003473

IL-1 beta scavenging by the type II IL-1 decoy receptor in human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1003473

Antiinflammatory cytokine responses during clinical sepsis and experimental endotoxemia: sequential measurements of plasma soluble interleukin (IL)-1 receptor type II, IL-10, and IL-13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1003473

Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1003473

Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1003473

Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1003473

IRAK-M is a negative regulator of Toll-like receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1003473

SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1003473

Divergent effects of LPS on expression of IL-1 receptor family members in mononuclear phagocytes in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1003473

Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1003473

A poxvirus protein that binds to and inactivates IL-18, and inhibits NK cell response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1003473

Targeting death and decoy receptors of the tumour-necrosis factor superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1003473

Osteoprotegerin ligand: a regulator of immune responses and bone physiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1003473

Death receptors: signaling and modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1003473

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1003473

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1003473

Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1003473

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1003473

Control of TRAIL-Induced Apoptosis by a Family of Signaling and Decoy Receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1003473

A membrane-bound Fas decoy receptor expressed by human thymocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1003473

Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1003473

A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1003473

Cloning and characterization of IL-22 binding protein, a natural antagonist of IL-10-related T cell-derived inducible factor/IL-22

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1003473

Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1003473

Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1003473

Enhanced interleukin (IL)-13 responses in mice lacking IL-13 receptor alpha 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1003473

The beta-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1003473

Cutting edge: scavenging of inflammatory CC chemokines by the promiscuous putatively silent chemokine receptor D6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1003473

21 January 2018

Identifiers

DOI

10.1189/JLB.1003473

1 reference

9 August 2017

1 reference